HHS Contracts Aim To Fund Adjuvant Vaccines Research
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK, Novartis and Iomai are awarded multi-million dollar contracts to fund adjuvant-based pandemic influenza vaccine development.